Xiangning "Sean" Deng
About Xiangning "Sean" Deng
Xiangning 'Sean' Deng serves as the Executive Director of Pharmaceutical Development and Manufacturing at Arcus Biosciences, bringing over 20 years of experience in CMC strategy for sterile injectable drugs. He has held significant roles at leading companies such as Amgen, Eli Lilly, and Abbott Laboratories, and is recognized as an expert in the biopharmaceutical CMC field.
Work at Arcus Biosciences
Xiangning Deng serves as the Executive Director of Pharmaceutical Development and Manufacturing at Arcus Biosciences. He has held this position since 2021, contributing to the company's efforts in developing and manufacturing pharmaceutical products. His role involves collaboration with Supply Chain and Contract Manufacturing Organization (CMO) partners to create and execute long-term manufacturing strategies aimed at ensuring a consistent supply of products to patients.
Education and Expertise
Xiangning Deng holds a Bachelor of Science in Molecular Biology from Nankai University and a Ph.D. in Molecular Biology from the University of Delaware. He also earned a Master of Business Administration (MBA) with a focus on Finance from Long Island University. His educational background supports his extensive expertise in Chemistry, Manufacturing, and Controls (CMC) strategy development and execution, particularly for sterile injectable drugs.
Background in Pharmaceutical Industry
Xiangning Deng has over 20 years of experience in the pharmaceutical industry, with a focus on CMC strategy for sterile injectable drugs. He has worked in various capacities at prominent companies, including Amgen Inc. as a Principal Scientist, Eli Lilly and Company as Director of Technical Services and Manufacturing, and Abbott Laboratories as a Senior Technical Support Scientist. His career has involved leading teams across multiple global sites to support aseptic manufacturing operations.
Achievements in CMC Strategy Development
Xiangning Deng is recognized as a biopharmaceutical CMC expert within the BioPhorum, Parenteral Drug Association, and the International Society of Pharmaceutical Engineers. He has developed and deployed a global, harmonized integrated manufacturing control strategy that encompasses process, raw material, and product quality. Additionally, he has implemented a contamination control strategy in compliance with EU Annex I requirements and has authored and reviewed essential technical documents for regulatory submissions.
Professional Experience Prior to Arcus Biosciences
Before joining Arcus Biosciences, Xiangning Deng held various positions in the pharmaceutical sector. He worked at Eli Lilly and Company from 2012 to 2021, leading Technical Services and Manufacturing Science. Prior to that, he was a Senior Product Support Scientist at Instrumentation Laboratory and a Postdoctoral Researcher at the University of California. His diverse experience has equipped him with a comprehensive understanding of pharmaceutical development and manufacturing processes.